Total Payments
$1,369
2024 Payments
$492.40
Companies
13
Transactions
49
Medicare Patients
1,642
Medicare Billing
$744,700
Payment Breakdown by Category
Food & Beverage$1,350 (98.6%)
Education$17.01 (1.2%)
Gifts$1.77 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,350 | 47 | 98.6% |
| Education | $17.01 | 1 | 1.2% |
| Gift | $1.77 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $294.99 | 13 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $272.46 | 5 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $177.49 | 4 | $0 (2022) |
| Travere Therapeutics, Inc. | $146.99 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.85 | 6 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $105.20 | 2 | $0 (2017) |
| Amgen Inc. | $75.28 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $45.29 | 2 | $0 (2024) |
| NxStage Medical, Inc. | $39.57 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $34.82 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $492.40 | 22 | AstraZeneca Pharmaceuticals LP ($179.66) |
| 2023 | $269.45 | 14 | AstraZeneca Pharmaceuticals LP ($115.33) |
| 2022 | $120.97 | 5 | NxStage Medical, Inc. ($39.57) |
| 2021 | $43.60 | 2 | AKEBIA THERAPEUTICS INC ($43.60) |
| 2019 | $113.06 | 1 | AKEBIA THERAPEUTICS INC ($113.06) |
| 2018 | $124.99 | 1 | Fresenius USA Marketing, Inc. ($124.99) |
| 2017 | $204.78 | 4 | Keryx Biopharmaceuticals, Inc. ($105.20) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $19.69 | General |
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.52 | General |
| 09/24/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.86 | General |
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.82 | General |
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: DIABETES | ||||||
| 06/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.77 | General |
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: DIABETES | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/27/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $29.43 | General |
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: DIABETES | ||||||
| 02/20/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.68 | General |
| 01/30/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $17.01 | General |
| Category: NEPHROLOGY | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: DIABETES | ||||||
| 11/29/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: DIABETES | ||||||
| 11/14/2023 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 344 | 932 | $366,850 | $138,350 |
| 2022 | 12 | 406 | 1,037 | $493,384 | $190,851 |
| 2021 | 9 | 425 | 1,085 | $556,100 | $207,095 |
| 2020 | 7 | 467 | 1,325 | $664,250 | $208,404 |
Total Patients
1,642
Total Services
4,379
Medicare Billing
$744,700
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 70 | 243 | $243,000 | $78,998 | 32.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 99 | 428 | $64,200 | $30,539 | 47.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 75 | $15,000 | $8,894 | 59.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 20 | 28 | $14,000 | $7,609 | 54.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 57 | $11,400 | $5,953 | 52.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 22 | 56 | $11,200 | $3,601 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,950 | $2,517 | 42.3% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 16 | 28 | $2,100 | $238.84 | 11.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 82 | 343 | $343,000 | $116,219 | 33.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 103 | 363 | $54,450 | $24,173 | 44.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 13 | 70 | $35,000 | $20,003 | 57.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 69 | 80 | $16,000 | $10,228 | 63.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 17 | 19 | $9,500 | $5,359 | 56.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 46 | $9,200 | $4,817 | 52.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,950 | $2,601 | 43.7% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 21 | 21 | $4,200 | $2,497 | 59.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 24 | 34 | $6,800 | $2,298 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 15 | $4,150 | $1,300 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $3,784 | $1,204 | 31.8% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 13 | 18 | $1,350 | $152.49 | 11.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 118 | 439 | $439,000 | $149,292 | 34.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 117 | 382 | $57,300 | $25,947 | 45.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 72 | 91 | $18,200 | $11,816 | 64.9% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 18 | 27 | $13,500 | $7,601 | 56.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 31 | $6,200 | $3,882 | 62.6% |
About Dr. Musa Njeru, MD
Dr. Musa Njeru, MD is a Nephrology healthcare provider based in South Richmond Hill, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2010. The National Provider Identifier (NPI) number assigned to this provider is 1598086258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Musa Njeru, MD has received a total of $1,369 in payments from pharmaceutical and medical device companies, with $492.40 received in 2024. These payments were reported across 49 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,350).
As a Medicare-enrolled provider, Njeru has provided services to 1,642 Medicare beneficiaries, totaling 4,379 services with total Medicare billing of $744,700. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location South Richmond Hill, NY
- Active Since 06/17/2010
- Last Updated 12/10/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1598086258
Products in Payments
- Velphoro (Drug) $272.46
- LOKELMA (Drug) $203.15
- Auryxia (Drug) $169.63
- JARDIANCE (Drug) $121.85
- AURYXIA (Drug) $113.06
- FARXIGA (Drug) $91.84
- KRYSTEXXA (Biological) $76.25
- NXSTAGE CARTRIDGE EXPRESS (Device) $39.57
- TARPEYO (Drug) $22.93
- RAYALDEE (Drug) $17.01
- Veltassa (Drug) $15.37
- Parsabiv (Drug) $14.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.